PRESS RELEASE published on 11/10/2025 at 15:00, 2 months 10 days ago Lir Life Sciences Corp. Formerly Blackbird Critical Metals Corp. Announces Closing of Acquisition of Lir Life Sciences Inc. Lir Life Sciences Corp. completes acquisition of Lir Inc., resumes trading on CSE under 'SKNY' ticker symbol. Dr. Edward Mills appointed CEO alongside new board and management members Acquisition Board Changes CSE Lir Life Sciences Corp. Dr. Edward Mills
Published on 01/20/2026 at 15:45, 1 hour 51 minutes ago Caldwell Announces New Sponsorship on Canada's Outstanding CEO of the Year(R)
Published on 01/20/2026 at 15:00, 2 hours 36 minutes ago Pivotree Partners with OroCommerce to Deliver Unmatched B2B eCommerce Powered by Mastered Data
Published on 01/20/2026 at 14:30, 3 hours 6 minutes ago Karbon-X Secures up to $25 Million in Strategic Financing to Accelerate Growth and Expand Global Climate Solutions Platform
Published on 01/20/2026 at 14:30, 3 hours 6 minutes ago Core Silver Confirms Expansion of Laverdiere Porphyry by 280 Metres Through Drilling
Published on 01/20/2026 at 14:30, 3 hours 6 minutes ago Innodata Awarded Prime Contract Position on U.S. Missile Defense Agency's IDIQ SHIELD Program
Published on 01/20/2026 at 16:15, 1 hour 21 minutes ago Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
Published on 01/20/2026 at 16:00, 1 hour 35 minutes ago Orion Innovation Recognized in Connected Product Engineering Services, Q4 2025 Analyst Evaluation
Published on 01/20/2026 at 15:30, 2 hours 5 minutes ago swissnet Group Secures Major Hospitality Technology Project in Abu Dhabi
Published on 01/20/2026 at 15:11, 2 hours 24 minutes ago Voyageurs du Monde: Bilan semestriel au 31 décembre 2025 du contrat de liquidité contracté avec la société de Bourse Gilbert Dupont
Published on 01/20/2026 at 07:30, 10 hours 6 minutes ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
Published on 01/20/2026 at 07:30, 10 hours 6 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/20/2026 at 07:30, 10 hours 6 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:45, 23 hours 51 minutes ago Calendrier de communication financière 2026